SCHEMBL21687455

SCHEMBL21687455

N#Cc1c(-c2cccc(-n3c4ccccc4c4ccccc43)c2)cccc1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HPGD P15428 4/20 0.33
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 2/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
GLA P06280 1/20 0.33
CRHBP P24387 1/20 0.33
KMT2A Q03164 1/20 0.33
CRHR2 Q13324 1/20 0.33
CHEK1 O14757 3/20 0.33
KCNH2 Q12809 3/20 0.33
MAPK1 P28482 2/20 0.33
PARP1 P09874 1/20 0.33
IKBKB O14920 2/20 0.32
CYP11B2 P19099 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687698 0.93 ALDH1A1 (0.33) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687717 0.92 KDM4E (0.38) KDM4EATML3MBTL1HPGDALDH1A1
SCHEMBL21688006 0.89 TDP2 (0.34) ALDH1A1LMNAMEN1KMT2AMAPK1
SCHEMBL21688076 0.88 KDM4E (0.41) KDM4EATML3MBTL1HPGDALDH1A1
SCHEMBL21687921 0.88 KDM4E (0.36) KDM4EATML3MBTL1HPGDALDH1A1
SCHEMBL21687771 0.88 CYP1A2 (0.33) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL26771772 0.86 L3MBTL1 (0.46) KDM4EATML3MBTL1ALDH1A1GAA
SCHEMBL21688193 0.86 CNR2 (0.37) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687630 0.85 KDM4E (0.36) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL21687775 0.85 SMN1; SMN2 (0.34) KDM4EATML3MBTL1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 KDM4E 2977/4885ATM 1151/4885L3MBTL1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.